vaccinia immune globulin (DynPort)
Jump to navigation
Jump to search
Introduction
Trademark: DynPort, FDA approved 2005
Indications
- treatment of complications of smallpox vaccination
Mechanism of action
- intravenous immune globulin Manufacturers: DynPort
More general terms
References
- ↑ Prescriber's Letter 13(2): 2006 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=220215&pb=PRL (subscription needed) http://www.prescribersletter.com